Medicare AdvantageCoverageMedium impact
MA08.007at, Medicare Part B vs. Part D Crossover Drugs
Independence Blue Cross·Pharmacy
Effective date
Jan 1, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage has updated their policy MA08.007at regarding crossover drugs that can be covered under both Medicare Part B and Part D. This policy clarifies billing requirements and coverage determinations for drugs that fall into both categories, effective January 1, 2026.
Action Required
Before January 1, 2026: Billing team must review the complete MA08.007at policy at the provided URL to understand specific requirements for crossover drugs covered under both Medicare Part B and Part D. Update billing workflows to ensure proper determination of Part B vs Part D coverage for applicable medications. Train staff on new crossover drug billing protocols.